One- and 2-year Flare Rates After Treat-to-Target and Tight-Control Therapy of Gout

Results From the NOR-Gout Study

Till Uhlig; Lars F. Karoliussen; Joe Sexton; Tore K. Kvien; Espen A. Haavardsholm; Fernando Perez-Ruiz; Hilde Berner Hammer

Disclosures

Arthritis Res Ther. 2022;24(88) 

In This Article

Conclusions

In conclusion, patients with gout frequently flare during the whole first year, especially during months 3–6, but flares are much less frequent during year 2 when treated with ULT. Baseline crystal depositions predict flares over 2 years, supporting ULT early during disease course.

processing....